| 1 |
23960782 | The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties. | 2012 Apr |
1 |
| 2 |
16849418 | An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. | 2006 Oct |
4 |
| 3 |
17032739 | Inhibition of RET tyrosine kinase by SU5416. | 2006 Oct |
6 |
| 4 |
11418488 | Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. | 2001 Jul 1 |
4 |